These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19068912)

  • 21. Letter by Madias regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    Madias JE
    Circulation; 2009 Jul; 120(3):e21; author reply e22. PubMed ID: 19620522
    [No Abstract]   [Full Text] [Related]  

  • 22. The sympathetic nervous system and pathophysiology of congestive heart failure.
    Farmer J
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):6-11. PubMed ID: 19667705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of physical training in patients with heart failure].
    Voors AA
    Ned Tijdschr Geneeskd; 2009; 153():A666. PubMed ID: 19785833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New pharmacological approaches in heart failure: should we treat the endothelium?].
    Richard V; Vercauteren M; Gomez E; Thuillez C
    Therapie; 2009; 64(2):93-100. PubMed ID: 19664402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM; Verrier RL
    Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation.
    Wongcharoen W; Chen SA
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):311-22. PubMed ID: 19296769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanical support for acute right ventricular failure: evolving surgical paradigms.
    Marquez TT; D'Cunha J; John R; Liao K; Joyce L
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):e39-40. PubMed ID: 19154879
    [No Abstract]   [Full Text] [Related]  

  • 28. Heart failure--new insights.
    Blum A
    Isr Med Assoc J; 2009 Feb; 11(2):105-11. PubMed ID: 19432040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental research on cardiotonic effect of active compound from raw and processing aconite roots].
    Wang L; Zhand D; Qu X; Zhang Z; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):596-9. PubMed ID: 19526792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure.
    Guazzi M
    Circ Heart Fail; 2008 Nov; 1(4):272-80. PubMed ID: 19808302
    [No Abstract]   [Full Text] [Related]  

  • 32. Implantable hemodynamic monitors.
    Tallaj JA; Singla I; Bourge RC
    Heart Fail Clin; 2009 Apr; 5(2):261-70. PubMed ID: 19249694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A home-based nurse-coached inspiratory muscle training intervention in heart failure.
    Padula CA; Yeaw E; Mistry S
    Appl Nurs Res; 2009 Feb; 22(1):18-25. PubMed ID: 19171291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "modern" view of heart failure: how did we get here?
    Katz AM
    Circ Heart Fail; 2008 May; 1(1):63-71. PubMed ID: 19808272
    [No Abstract]   [Full Text] [Related]  

  • 35. Emerging diuretics for the treatment of heart failure.
    Sedghi Y; Gaddam KK; Ventura HO
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):195-204. PubMed ID: 19196235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated afterload, neuroendocrine stimulation, and human heart failure increase BNP levels and inhibit preload-dependent SERCA upregulation.
    Toischer K; Kögler H; Tenderich G; Grebe C; Seidler T; Van PN; Jung K; Knöll R; Körfer R; Hasenfuss G
    Circ Heart Fail; 2008 Nov; 1(4):265-71. PubMed ID: 19808301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Daily walking performance as an independent predictor of advanced heart failure: Prediction of exercise capacity in chronic heart failure.
    Jehn M; Schmidt-Trucksäss A; Schuster T; Weis M; Hanssen H; Halle M; Koehler F
    Am Heart J; 2009 Feb; 157(2):292-8. PubMed ID: 19185636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic monitoring in the diagnosis and management of heart failure. Preface.
    Abraham WT; Baliga RR
    Heart Fail Clin; 2009 Apr; 5(2):xv. PubMed ID: 19249683
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient education guide. Understanding heart failure.
    Nursing; 2009; 39 Suppl Cardiac():7-8. PubMed ID: 19342941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.